Epigen Experts by MTL Epitherapeutics Inc. is an Epigenetics Montreal company, a subsidiary of HKG Epitherapeutics, that was founded in 2016 by Prof. Moshe Szyf, a world pioneer in the exciting and rapidly emerging science of Epigenetics.
A Montreal company, dedicated to harnessing the untapped power and possibilities of Epigenetics.
With an emphasis on the evolving markets in Canada and our immediate focus on tests, prevention and early treatment for common diseases such as cancer, our mission is to positively impact the healthcare, well-being, quality of life and promoting healthy aging for large populations of people, worldwide.
Simply stated, the science of Epigenetics centers on DNA Methylation (a simple biochemical process) that changes a mark on your DNA when cancer or other catastrophic diseases may develop.
We also help researchers advance the clinical study of Epigenetics by providing the state of art DNA methylation analysis services.
FOCUS ON PREVENTION. THE CHALLENGE
While the company is new, Szyf’s three decades of ground-breaking research and cutting-edge innovations in Epigenetics — how it occurs and how it is passed from generation to generation — has already disrupted medical science with its potential to detect, diagnose, prevent or cure diseases.
MTL Epitherapeutics believes the ability to measure and diagnose these changes in DNA will not only revolutionize the impact on fighting disease but on regulating our critical cardiovascular, neurological, reproductive, and detoxification systems as well.
We believe that integrating our novel diagnostics into these developing markets will greatly affect the quality of health care for the people of these countries. We are interested in building diagnostic licensing partnerships in this area, as they become available.
We invite you to contact us for more information. Join our mission to be a major force in the explosive new science of Epigenetics by becoming a partner and an influencer in global healthcare.